TRP-8802 demonstrated significant and prolonged improvement in primary endpoints for all five patients Across all patients treated with TRP-8802, daily binge eating episodes were reduced by an average ...
KELOWNA, BC / ACCESSWIRE / December 11, 2023 / Tryp Therapeutics Inc. ("Tryp" or the "Company") (CSE:TRYP), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin ...
Deep-rooted psychological factors are often at the core of eating disorders, and psilocybin is increasingly showing promise. As treatment advances, Tryp Therapeutics developed psilocybin-based ...
KELOWNA, BC / ACCESSWIRE / May 1, 2024 / Tryp Therapeutics, Inc. ("Tryp" or the "Company") (CSE:TRYP)(OTCQB:TRYPF) and Exopharm Limited ACN 163 765 991 ("Exopharm") are pleased to announce that ...
Psilocybin, the active ingredient found in what's often referred to as "magic mushrooms," has been a popular topic of late. The substance has experienced a surge in popularity over the past few years, ...
The TRYP by WyndhamTM select-service hotel brand announced the launch of a new global marketing and advertising campaign and the debut of the brand’s revamped consumer website – www.tryphotels.com – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results